Senior Appointments Made at Sanofi Türkiye

Sanofi Turkey Announces Senior Management Appointments Sanofi Turkey has announced senior management changes within its Specialized Treatments Business Unit, which focuses on specialized therapeutic areas including rare diseases, MS, immunology, hematology and oncology.

Derya Adilce appointed Director of Sanofi Turkey, Iran Levant Rare Diseases Business Unit

Since 2018, Derya Adilce has served at Sanofi as Manager of New Launches, Director of Innovation and New Launches Marketing, and Director of Rare Blood Diseases Business Unit. Prior to Sanofi, she held positions in sales, market access, marketing and product management at companies including Johnson & Johnson, Novartis and NovoNordisk. Adilce graduated from Boğaziçi University's International Trade Department following her secondary education at Pertevniyal High School, and completed her master's degree in Business Administration at the same university. With extensive national and international sales and marketing experience across different firms and therapeutic areas, Derya Adilce has served as Director of the Rare Diseases Business Unit for the Turkey, Iran and Levant region within Sanofi's Specialized Treatments Business Unit since April 2021.

Derya Pak appointed Director of Sanofi Turkey, Iran and Levant Oncology Business Unit

Since 2012, Derya Pak has held marketing positions at Sanofi. Prior to Sanofi, she worked in sales and product management at companies including GRI, Novartis, Sanovel and TEVA. Derya Pak graduated from Boğaziçi University's Molecular Biology and Genetics Department in 2003, and completed the Business Administration undergraduate program at Boğaziçi University in 2007. Following 10 years at Sanofi with experience in Brand Management in the Oncology field, Derya Pak now serves as Head of Oncology for the Turkey, Iran and Levant region within Sanofi's Specialized Treatments Business Unit.

Mine Sayıt appointed Director of Sanofi Turkey, Iran and Levant MS and Rare Blood Diseases Business Unit

  Since 2006, Mine Sayıt has held significant positions in sales, marketing and brand management at Sanofi. She continues her 16-year career at Sanofi as Director of the MS and Rare Blood Diseases Business Unit for the Turkey, Iran and Levant region. Following her secondary education at Istanbul Notre Dame de Sion French High School, Mine Sayıt graduated from Galatasaray University's Economics Department in 2004, and immediately thereafter completed her master's degree in Marketing Strategy in France.